Taiwan FDA registration 6c2e08b6ab27d8b8bfef292e4d0100cd
Pure Biotech Cannabis Test Reagent
TW: 璞笠生技大麻檢驗試劑
Taiwan·Risk Class 2·PULI BIOTECHNOLOGY CO., LTD.·Registered Aug 15, 2022 – Aug 15, 2027ActiveRegistration details
- Analysis ID
- 6c2e08b6ab27d8b8bfef292e4d0100cd
Company information
- Manufacturer
- PULI BIOTECHNOLOGY CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PULI BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- The concentration of cannabis (THC) in human urine was qualitatively detected, and the threshold standard for THC was set to 50 ng/ml. Can be used by professionals and general staff.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3870 Cannabis Trial System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Aug 15, 2022
- Expiry Date
- Aug 15, 2027
About this record
Access comprehensive regulatory information for Pure Biotech Cannabis Test Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6c2e08b6ab27d8b8bfef292e4d0100cd and manufactured by PULI BIOTECHNOLOGY CO., LTD.. The authorized representative in Taiwan is PULI BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices